ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,884.80
      0.46%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.68
      -0.78%
      Bitcoin
      63,823.67
      -1.59%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      01/31/20236:30PMGlobeNewswire Inc.Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)NASDAQ:MESOMesoblast Limited
      01/31/20234:40AMGlobeNewswire Inc.Appendix 4C Quarterly Activity ReportNASDAQ:MESOMesoblast Limited
      01/20/20239:00AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MESOMesoblast Limited
      01/03/20236:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MESOMesoblast Limited
      12/29/20226:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      12/27/20226:16AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MESOMesoblast Limited
      12/23/20226:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MESOMesoblast Limited
      12/22/20227:18PMGlobeNewswire Inc.Mesoblast and Oaktree Extend Availability Period of Undrawn Tranches of Financing FacilityNASDAQ:MESOMesoblast Limited
      12/20/20226:38AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MESOMesoblast Limited
      12/20/20226:37AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MESOMesoblast Limited
      12/20/20226:36AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MESOMesoblast Limited
      12/20/20226:26AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:MESOMesoblast Limited
      12/20/20226:19AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MESOMesoblast Limited
      12/07/20226:17AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      11/23/20227:25AMTipRanksChardan Capital Sticks to Its Sell Rating for Mesoblast (MESO)NASDAQ:MESOMesoblast Limited
      11/22/20226:32PMGlobeNewswire Inc.Children Treated With Remestemcel-L Show Long-Term Survival Through Four Years in Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)NASDAQ:MESOMesoblast Limited
      11/22/20226:00PMGlobeNewswire Inc.Mesoblast Reports Financial Results and Operational Highlights for the Period Ended September 30, 2022NASDAQ:MESOMesoblast Limited
      11/21/20226:00AMGlobeNewswire Inc.Mesoblast Financial Results and Corporate Update WebcastNASDAQ:MESOMesoblast Limited
      11/16/20224:04PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      11/07/20226:42AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      10/30/20227:50PMGlobeNewswire Inc.Mesoblast Operational and Financial Highlights for Quarter Ended September 30, 2022NASDAQ:MESOMesoblast Limited
      10/03/20221:13PMDow Jones NewsMesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-LNASDAQ:MESOMesoblast Limited
      10/02/20227:51PMGlobeNewswire Inc.Mesoblast Submits New Information to FDA IND File in Response to Items in the CRL to the Remestemcel-L BLA for SR-aGVHDNASDAQ:MESOMesoblast Limited
      09/30/20226:49AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MESOMesoblast Limited
      09/23/20227:53AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      08/31/20228:13AMTipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Resmed (RMD), Mesoblast (MESO) and Baudax Bio (BXRX)NASDAQ:MESOMesoblast Limited
      08/30/20227:05PMGlobeNewswire Inc.Mesoblast Reports Financial Results and Operational Highlights for Fiscal Year Ended June 30, 2022NASDAQ:MESOMesoblast Limited
      08/29/20228:14PMGlobeNewswire Inc.Mesoblast Corporate Update and Financial Results WebcastNASDAQ:MESOMesoblast Limited
      08/18/20227:00AMGlobeNewswire Inc.Jane Bell Joins Mesoblast BoardNASDAQ:MESOMesoblast Limited
      08/16/20227:38AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO